Facing $4B in claims, Insys doubts ability to pay out via Chapter 11...

09/20/19

Facing $4B in claims, Insys doubts ability to pay out via Chapter 11  BioPharma Dive

Facing more than $4 billion in claims from 8,000-plus filings, Insys Therapeutics does not expect to come close to fulfilling all outstanding demands, but has ...

[more]